We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

47 hedge funds and large institutions have $26.9M invested in Galera Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more call options, than puts

Call options by funds: $1.79M | Put options by funds: $824K

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

7% more funds holding

Funds holding: 44 → 47 (+3)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

47% less capital invested

Capital invested by funds: $50.6M → $26.9M (-$23.7M)

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
12
Closed
9
Calls
$1.79M
Puts
$824K
Net Calls
+$967K
Net Calls Change
-$2.02M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.14M
2
Two Sigma Investments
Two Sigma Investments
New York
+$416K
3
BlackRock
BlackRock
New York
+$389K
4
Citadel Advisors
Citadel Advisors
Florida
+$361K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$348K

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$1.21M
2
Morgan Stanley
Morgan Stanley
New York
-$482K
3
CS
Credit Suisse
Switzerland
-$450K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$439K
5
Millennium Management
Millennium Management
New York
-$255K
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
26
Simplex Trading
Illinois
$44K -$234K -89,666 -83%
Marshall Wace
27
Marshall Wace
United Kingdom
$43K -$985 -378 -2%
Northern Trust
28
Northern Trust
Illinois
$43K – – –
Goldman Sachs
29
Goldman Sachs
New York
$38K -$16.4K -6,311 -28%
SFI
30
Susquehanna Fundamental Investments
Pennsylvania
$36K +$39.1K +15,000 New
HSBC Holdings
31
HSBC Holdings
United Kingdom
$31K – – –
VF
32
Virtu Financial
New York
$30K +$32.5K +12,461 New
TWMP
33
Taylor Wealth Management Partners
Massachusetts
$28K – – –
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$22K -$1.62K -622 -6%
UBS Group
35
UBS Group
Switzerland
$15K +$318 +122 +2%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$15K +$15.1K +5,800 New
TWA
37
TCI Wealth Advisors
Arizona
$14K – – –
Morgan Stanley
38
Morgan Stanley
New York
$13K -$482K -184,968 -97%
Bank of America
39
Bank of America
North Carolina
$12K -$25.3K -9,718 -67%
Wells Fargo
40
Wells Fargo
California
$5K – – –
FDCDDQ
41
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5K – – –
CG
42
Cutler Group
California
$4K +$261 +100 +6%
US Bancorp
43
US Bancorp
Minnesota
$3K -$25K -9,579 -87%
TRCT
44
Tower Research Capital (TRC)
New York
$3K +$3.43K +1,316 New
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
$2K – – –
ACP
46
Acuta Capital Partners
California
– -$1.21M -262,500 Closed
CS
47
Credit Suisse
Switzerland
– -$450K -97,946 Closed
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
– -$439K -96,027 Closed
Squarepoint
49
Squarepoint
New York
– -$142K -30,880 Closed
TSS
50
Two Sigma Securities
New York
– -$108K -23,463 Closed
1
2
3

GRTX Hedge Fund Activity: Q1 2022 in Review

47 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q1 2022, worth a combined $26.9M — down 47% from $50.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GRTX positions and 9 closed out — a net gain of 3 holders — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.14M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $1.21M sold.

  • 47 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q1 2022, up from 44 in Q4 2021.
  • Funds reported $26.9M of Galera Therapeutics, Inc. Common Stock stock for Q1 2022, down 47% quarter-over-quarter.
  • 12 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q1 2022 and 9 closed out, a net change of +3 holders.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q1 2022 was Renaissance Technologies, an estimated $1.14M added.
  • The largest Galera Therapeutics, Inc. Common Stock seller in Q1 2022 was Acuta Capital Partners, an estimated $1.21M sold.

Based on aggregated 13F filings for Q1 2022.